Quantifying antibody-mediated neutralisation of SARS-CoV-2 directly in serum
29 May, 2021 | Newsletters
|Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum
New Scientific Publication – ACS Editors’ Choice
“Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum” was recently published in ACS Infectious Diseases and selected for ACS Editors’ Choice because of “its potential for broad public interest.“
This paper showcases: A new type of in-solution receptor-binding competition assay that quantifies the affinity, concentration, and neutralisation potential of antibodies against the SARS-CoV-2 spike protein The ability of this platform to accurately and quantitatively profile the underlying protein interactions directly in serum
To read the full paper click here
If you have any questions or would like to see how the unique capabilities of the Fluidity One-W Serum can support your research, please get in touch with us using one of the links below.
Request training or a demo
Click here for sample testing
Click here for service support
Encouragement Award 2021
The ATA Scientific Encouragement Award aims to provide young scientists with financial assistance to further their education and attend scientific meetings and conferences.
Congratulations to all our previous winners.
To find out who won, please click here.
Enter our award for 2021 – click here